135 related articles for article (PubMed ID: 22487848)
1. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection.
Mansouri D; Mahdaviani SA; Khalilzadeh S; Mohajerani SA; Hasanzad M; Sadr S; Nadji SA; Karimi S; Droodinia A; Rezaei N; Linka RM; Bienemann K; Borkhardt A; Masjedi MR; Velayati AA
Int Arch Allergy Immunol; 2012; 158(4):418-22. PubMed ID: 22487848
[TBL] [Abstract][Full Text] [Related]
2. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
[TBL] [Abstract][Full Text] [Related]
3. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
4. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement.
Hänel M; Fiedler F; Thorns C
Onkologie; 2001 Oct; 24(5):491-4. PubMed ID: 11694778
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.
Liu QF; Fan ZP; Luo XD; Sun J; Zhang Y; Ding YQ
Transpl Infect Dis; 2010 Aug; 12(4):284-91. PubMed ID: 20345506
[TBL] [Abstract][Full Text] [Related]
7. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
Bienemann K; Borkhardt A; Klapper W; Oschlies I
Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
[TBL] [Abstract][Full Text] [Related]
8. Multiple pulmonary nodules caused by B-cell post-transplant lymphoproliferative disorder after bone marrow transplantation: monitoring Epstein-Barr virus viral load.
Shoji N; Ohyashiki JH; Suzuki A; Kubota N; Kimura Y; Matsubayashi J; Mukai K; Ohyashiki K
Jpn J Clin Oncol; 2003 Aug; 33(8):408-12. PubMed ID: 14523062
[TBL] [Abstract][Full Text] [Related]
9. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
[TBL] [Abstract][Full Text] [Related]
10. [Elevation of Epstein-Barr virus (EBV)-DNA in the peripheral blood of a patient with age-related EBV-associated B-cell lymphoproliferative disorder].
Tanioka R; Mori S; Nakanishi T; Fujita S; Nakamichi N; Tajima K; Uemura Y; Amakawa R; Kishimoto Y; Fukuhara S
Rinsho Ketsueki; 2007 Nov; 48(11):1492-7. PubMed ID: 18080508
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders presented as interstitial pneumonia; successful recovery with rituximab.
Kunitomi A; Arima N; Ishikawa T
Haematologica; 2007 Apr; 92(4):e49-52. PubMed ID: 17562592
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative disorder of the airway of an adolescent without immunodeficiency.
Boesch RP; Daines M; Kaul A; Cotton R; Amin R
Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1591-4. PubMed ID: 15963576
[TBL] [Abstract][Full Text] [Related]
14. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders.
Shamriz O; Vilk SR; Wolf DG; Ta-Shma A; Averbuch D; Weintraub M; Stepensky P
Clin Immunol; 2014 Apr; 151(2):79-83. PubMed ID: 24584040
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.
Zhu K; Chen J; Chen S
Hematology; 2005 Oct; 10(5):365-70. PubMed ID: 16273722
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after a cord blood stem cell transplantation presenting with pulmonary nodules.
Shimasaki N; Mori T; Shimada H; Sugita M; Higuchi M; Mukai M; Morio T; Okamoto S
J Pediatr Hematol Oncol; 2004 Feb; 26(2):124-7. PubMed ID: 14767205
[TBL] [Abstract][Full Text] [Related]
18. Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation.
Liu Q; Xuan L; Liu H; Huang F; Zhou H; Fan Z; Zhao K; Wu M; Xu L; Zhai X; Zhang F; Liu C; Sun J; Huang X
Am J Hematol; 2013 Jul; 88(7):550-5. PubMed ID: 23564232
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
[TBL] [Abstract][Full Text] [Related]
20. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.
Youssefian L; Vahidnezhad H; Yousefi M; Saeidian AH; Azizpour A; Touati A; Nikbakht N; Hesari KK; Adib-Sereshki MM; Zeinali S; Mansoori B; Jazayeri A; Karamzadeh R; Fortina P; Jouanguy E; Casanova JL; Uitto J
Clin Infect Dis; 2019 May; 68(11):1938-1941. PubMed ID: 30778533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]